《现代医学与健康研究》编辑部官网!【中国医师协会系列期刊】
经皮射频热凝治疗对慢性颈肩痛患者疼痛 与炎性因子的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R681.5

基金项目:


Effects of percutaneous radiofrequency thermocoagulation on pain and inflammatory factors in patients with chronic neck and shoulder pain
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探究经皮射频热凝治疗慢性颈肩痛对患者疼痛及血清 C- 反应蛋白(CRP)、白细胞介素 -1β(IL-1β)、前列腺素 E2 (PGE2)、白细胞介素 -10(IL-10)、5- 羟色胺(5-HT)水平的影响,为临床治疗提供参考依据。方法 按照随机数字表法将湛江南油 医院 2018 年 1 月至 2021 年 1 月收治的慢性颈肩痛患者(50 例)分成对照组(25 例,药物结合推拿、针灸治疗)与观察组(25 例,经 皮射频热凝治疗),对照组患者以 7 d 为 1 个疗程,共治疗 2 个疗程,观察组患者治疗 1 次,均随访 3 个月。比较治疗后两组患者临床 疗效,随访 3 个月后的总复发率,治疗前与治疗 2 周后临床症状评分、血清 CRP、IL-1β、PGE2、IL-10、5-HT 水平,治疗前与治疗 1、 2 周后视觉模拟疼痛量表(VAS),以及治疗前与治疗后 1、3 个月生活质量量表(SF-36)评分。结果 经治疗观察组患者临床总有效率 为 96.00%,显著高于对照组的 68.00%;与治疗前比,治疗 2 周后两组患者疼痛、肿胀、功能受限症状评分,血清 CRP、IL-1β、PGE2、 5-HT 水平及治疗 1~2 周后 VAS 评分均显著降低,且观察组显著低于对照组,而治疗 2 周后两组患者 IL-10 水平与治疗后 1、3 个月两组 患者 SF-36 评分均显著升高,且观察组显著高于对照组(均P<0.05);随访结束后观察组患者总复发率低于对照组,但组间比较,差异 无统计学意义(P>0.05)。结论 经皮射频热凝治疗可改善慢性颈肩痛患者临床症状,降低患者机体炎性因子水平,缓解颈肩疼痛,提高 患者生活质量,且疗效显著,同时与药物结合推拿、针灸比较,该治疗方案可一定程度上降低颈肩疼痛的复发率。

    Abstract:

    Objective To investigate the effects of percutaneous radiofrequency thermocoagulation on pain and serum C-reactive protein (CRP), interleukin-1β (IL-1β), prostaglandin E2 (PGE2), interleukin-10 (IL-10), 5-hydroxytryptamine (5-HT) levels, in order to provide reference for clinical treatment. Methods According to the random number table method, the patients with chronic neck and shoulder pain (50 cases) admitted to Zhanjiang Nanyou Hospital from January 2018 to January 2021 were divided into the control group (25 cases, drug combined with massage and acupuncture) and the observation group (25 cases, percutaneous radiofrequency thermocoagulation), the patients in the control group were treated for 7 days as a course of treatment, with a total of 2 courses of treatment, the patients in the observation group were treated once, and all were followed up for 3 months. The clinical efficacy of the two groups of patients after treatment, overall recurrence rate after 3 months of follow-up were compared, clinical symptom scores, serum CRP, IL-1β, PGE2, IL-10, 5-HT levels before treatment and after 2 weeks of treatment, visual analogue scale (VAS) before treatment and after 1~2 weeks of treatment , and the quality of life scale (SF-36) score before treatment and after 1~3 months treatment were compared between the two groups. Results After treatment, the total clinical effective rate of the observation group was 96.00%, which was significantly higher than 68.00% of the control group; compared with before treatment, the symptom scores of pain, swelling and functional limitation, serum CRP, IL-1β, PGE2, 5-HT levels and VAS scores after 1~2 weeks of treatment in the two groups significantly decreased, and the observation group was significantly lower than the control group, the levels of IL-10 after 2 weeks of treatment and the SF-36 scores at 1 and 3 months after treatment in the two groups significantly increased, and the observation group was significantly higher than the control group (all P<0.05); after follow-up, statistics showed that the total recurrence rate of patients in the observation group was lower than that in the control group, but there was no significant difference between the two groups (P>0.05). Conclusion Percutaneous radiofrequency thermocoagulation can improve the clinical symptoms of patients with chronic neck and shoulderpain, reduce the level of inflammatory factors, relieve neck and shoulder pain, improve the quality of life, and has a significant effect, at the same time, compared with drugs combined with massage and acupuncture, this treatment plan can reduce the recurrence rate of neck and shoulder pain to a certain extent.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-23
  • 出版日期:

地址:北京朝阳区北沙滩1号16信箱

邮编:100083

电话:010-64882183 64883630

E-mail:xdyx2020@vip.163.com


温馨提示:建议您使用Chrome80、火狐74+、IE11浏览器 ,当您的浏览器版本过低,可能会影响部分功能正常使用。

现代医学与健康研究 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司